22 results
8-K
EX-3.2
CELL
Bruker Cellular Analysis, Inc.
2 Oct 23
Completion of Acquisition or Disposition of Assets
8:47am
and vote at such meeting, and the place within the city or other municipality or community at which the list of stockholders may be examined, shall
SC 14D9
CELL
Bruker Cellular Analysis, Inc.
31 Aug 23
Tender offer solicitation
4:47pm
, stating that “proof of value by any techniques or methods which are generally considered acceptable in the financial community and otherwise admissible
SC TO-T
EX-99
CELL
Bruker Cellular Analysis, Inc.
31 Aug 23
Third party tender offer statement
4:11pm
, as amended.
A middleman known in the investment community as a nominee or custodian.
A futures commission merchant registered with the Commodity
425
ISO
IsoPlexis Corp
22 Dec 22
Business combination disclosure
6:19pm
in the proteomic space and a powerful contributor to the broader scientific community, we're known for our leading IsoCode cellular behavior multiplexing
425
EX-10.2
ekzk8 cqobm8oijz9
21 Dec 22
Business combination disclosure
5:28pm
8-K
EX-10.2
37b4vv
21 Dec 22
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
5:27pm
DEF 14A
zvjr y0m7wy
1 Apr 21
Definitive proxy
12:00am
424B4
c46dp psy
19 Nov 20
Prospectus supplement with pricing info
4:09pm
DRS
v8ejw8ejojtq1i
6 Nov 20
Draft registration statement
12:00am
424B4
8k5gff6e0eh7
17 Jul 20
Prospectus supplement with pricing info
4:33pm
S-1
EX-10.1
ckfaczr2
26 Jun 20
IPO registration
4:31pm
S-1
irkr g7esqsb663ijvxp
26 Jun 20
IPO registration
4:31pm
DRS/A
EX-10.1
ck0vfbf2p6e4twdqie
12 Jun 20
Draft registration statement (amended)
12:00am